Lifeward

Company Overview

Snapshot

Founded in June 2001, Lifeward operates with 11–50 employees and has raised a total of $257.92 million across 22 funding rounds from 12 investors. The company secured growth capital in July 2026 from lead investor Oramed Pharmaceuticals.

Business overview

Lifeward is a Health Tech & Life Sciences company focused on developing groundbreaking solutions for individuals with physical limitations or disabilities. The company's portfolio includes innovative products such as the ReWalk Exoskeleton and ReStore Exo-Suit. Lifeward operates in the Digital Accessibility Solutions and Medical Devices sectors, serving healthcare providers and patients globally.

Strategic signal

In May 2026, Lifeward announced new ReWalk data presented at the ASIA 2026 Conference, demonstrating a comprehensive longitudinal safety analysis for its powered exoskeleton. This highlights the company's ongoing commitment to clinical validation and product safety, which is crucial for market adoption and regulatory approvals in the medical device industry, signaling continued innovation and reliability to investors.

Company Intelligence Q&A

What was a significant recent financial event for Lifeward?

In July 2026, Lifeward secured growth capital in a strategic financing round, with Oramed Pharmaceuticals participating as a lead investor.

What was the most recent public offering by Lifeward?

In June 2025, Lifeward announced the pricing of a $2.6 million public offering on NASDAQ.

What was a key acquisition made by Lifeward?

In August 2023, Lifeward acquired AlterG, a move aimed at accelerating commercial expansion and driving profitability.

What recent data was presented regarding Lifeward's ReWalk exoskeleton?

In May 2026, Lifeward announced new ReWalk data presented at the ASIA 2026 Conference, demonstrating a comprehensive longitudinal safety analysis for its powered exoskeleton.

When did Lifeward go public?

Lifeward became public on NASDAQ in September 2014, raising $36 million in its Initial Public Offering.